D.A. Davidson and CO. boosted its holdings in ADMA Biologics Inc (NASDAQ: ADMA) by 21.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissi
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
RAMSEY, N.J. and BOCA RATON, Fla.
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $15.6, denoting a +2.77% move from the preceding trading day.
Adma Biologics (ADMA) closed at $14.56 in the latest trading session, marking a -3.51% move from the prior day.

3 Biotech Stocks I Am Accumulating

02:30pm, Wednesday, 15'th Oct 2025
The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic about this area of the market. Many biotech/biopharma stocks also make good covered call tra
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Adma Biologics (ADMA) concluded the recent trading session at $15.05, signifying a +2.66% move from its prior day's close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
In the latest trading session, Adma Biologics (ADMA) closed at $15.32, marking a -2.17% move from the previous day.
In the latest trading session, Adma Biologics (ADMA) closed at $15.91, marking a -1.55% move from the previous day.
Adma Biologics (ADMA) closed the most recent trading day at $15.3, moving 5.03% from the previous trading session.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
ADMA Biologics' earnings are surging due to higher plasma yield and a profitable shift toward premium IG brands, boosting margins. FDA approval of yield-enhancement technology increases finished IG ou
ADMA's growth remains centered on Asceniv, Bivigam, and NABI-HB. These are its main value drivers today. ADMA Biologics' recent Q2 report showed that the company is working on enhancing its plasma yie
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE